Health & Fitness
Wed, January 18, 2012
LEXINGTON, Ky.--([ BUSINESS WIRE ])--MedPro Safety Products, Inc. (OTCBB: MPSP), a leading developer of transformational technologies that enable safer medication delivery and blood collection, will participate in two leading drug delivery industry conferences in the coming weeks.
"We set an aggressive schedule of conferences and industry events for 2012"
Peter Forceville, recently appointed Vice President for Business Development, Europe and Asia, will represent MedPro in London at the European Pre-Filled Syringes Conference, January 18 a" 19, 2012. MedPro will exhibit its drug delivery platform a" which includes its pre-filled passive [ safety syringe ], prefilled [ IV shuttle ], and passive safety [ hypodermic needle ].
MedPro will also exhibit at the Drug Delivery Partnerships Conference in Las Vegas, January 25 a" 27, 2012, at which Garyen Denning, MedPro Executive Vice President, will also speak. Mr. Denningas presentation, aTurning Prefilled Upside Down,a will begin at 11:45am on January 27, 2012, part of the Drug Delivery Partnerships Agenda.
aWe set an aggressive schedule of conferences and industry events for 2012,a said Wm. Craig Turner, Chairman and CEO of MedPro. aAs we broaden our scope from safety sharps to include other devices that enable greater patient safety, we are looking to expand our strategic partnerships with industry leaders to commercialize our robust pipeline. Drug delivery and packaging industry events are excellent opportunities to advance our agenda, meet with potential partners, and display our drug delivery and blood collection technologies.a
About MedPro Safety Products, Inc.
Headquartered in Lexington, Kentucky, MedPro Safety Products, Inc. is a leading developer of safer medication delivery and blood collection systems.The Company licenses, develops and manufactures transformational technologies marketed through its global medical device partners.MedProas products address multiple product categories within the medication delivery (injection and infusion) and blood collection (blood collection sets and blood tube holders) markets.Unlike competitive products currently available on the market, MedProas products incorporate safety features that operate without user activation, and therefore require little or no clinician training to use.The total global market opportunity for safer medication delivery and blood collection products is believed to be more than $6 billion.For additional information, please refer to the aInvestor Relationsa link on the Companyas website ([ www.medprosafety.com ]).